The bacterium amplified tumor numbers and led to accelerated tumorigenesis in both the small intestine and colon, infiltration of distinct myeloid cell subsets into the tumors, and an NF-κB-driven proinflammatory profile, like F. nucleatum-positive colorectal carcinomas in humans. The gene discussed is NFKB1; the disease is neoplasm.